{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:32:02Z","timestamp":1792650722736,"version":"4.5.0"},"reference-count":86,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autoimmune disease development depends on multiple factors, including genetic and environmental. Abnormalities such as sialylation levels and\/or quality have been recently highlighted. The adjunction of sialic acid at the terminal end of glycoproteins and glycolipids is essential for distinguishing between self and non-self-antigens and the control of pro- or anti-inflammatory immune reactions. In autoimmunity, hyposialylation is responsible for chronic inflammation, the anarchic activation of the immune system and organ lesions. A detailed characterization of this mechanism is a key element for improving the understanding of these diseases and the development of innovative therapies. This review focuses on the impact of sialylation in autoimmunity in order to determine future treatments based on the regulation of hyposialylation.<\/jats:p>","DOI":"10.3390\/ijms22073402","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T06:59:42Z","timestamp":1616741982000},"page":"3402","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-2546","authenticated-orcid":false,"given":"Anne","family":"Bordron","sequence":"first","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Morel","sequence":"additional","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bagacean","sequence":"additional","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"},{"name":"CHU de Brest, Laboratory of Immunolgy, 29200 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryvonne","family":"Dueymes","sequence":"additional","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"},{"name":"CHU de Brest, Laboratory of Immunolgy, 29200 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pochard","sequence":"additional","affiliation":[{"name":"CHU de Brest, Laboratory of Immunolgy, 29200 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-3799","authenticated-orcid":false,"given":"Anne","family":"Harduin-Lepers","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS UMR 8576\u2014UGSF\u2014Unit\u00e9 de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-3223","authenticated-orcid":false,"given":"Christophe","family":"Jamin","sequence":"additional","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"},{"name":"CHU de Brest, Laboratory of Immunolgy, 29200 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-5541","authenticated-orcid":false,"given":"Jacques-Olivier","family":"Pers","sequence":"additional","affiliation":[{"name":"Univ Brest, Inserm, LBAI, UMR1227 Brest, France"},{"name":"CHU de Brest, Laboratory of Immunolgy, 29200 Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","article-title":"Female predominance and X chromosome defects in autoimmune diseases","volume":"33","author":"Invernizzi","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","article-title":"The genetics and epigenetics of autoimmune diseases","volume":"33","author":"Hewagama","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2012.01.010","article-title":"The role of environmental factors in the pathogenesis of non-organ-specific autoimmune diseases","volume":"26","author":"Caldas","year":"2012","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","article-title":"Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity","volume":"140","author":"Cornacchia","year":"1988","journal-title":"J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity\u2014Friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/ard.60.3.223","article-title":"Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA","volume":"60","author":"Hutchinson","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e89703","DOI":"10.1172\/jci.insight.89703","article-title":"Estrogens regulate glycosylation of IgG in women and men","volume":"2","author":"Ercan","year":"2017","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fc\u03b3 Receptor Function and the Design of Vaccination Strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jmr.2155","article-title":"Avidity confers Fc\u03b3R binding and immune effector function to aglycosylated immunoglobulin G1: Fc\u03b3R Binding and Effector Function of Aglycosylated IgG1","volume":"25","author":"Nesspor","year":"2012","journal-title":"J. Mol. Recognit."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3899\/jrheum.110584","article-title":"IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis","volume":"39","author":"Troelsen","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R Binding and ADCC Activity of Human IgG Allotypes","volume":"11","author":"Bentlage","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_12","first-page":"767","article-title":"Aberrant glycosylation in autoimmune disease","volume":"38","author":"Li","year":"2020","journal-title":"Clin. Exp. Rheumatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/glycob\/10.3.321","article-title":"Cloning of the human cDNA which can complement the defect of the yeast mannosyltransferase I-deficient mutant alg 1","volume":"10","author":"Takahashi","year":"2000","journal-title":"Glycobiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/10409238.2014.976606","article-title":"Polysialic acid: Biosynthesis, novel functions and applications","volume":"49","author":"Colley","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Simon, P., Feuerstacke, C., Kaese, M., Saboor, F., Middendorff, R., and Galuska, S.P. (2015). Polysialylation of NCAM Characterizes the Proliferation Period of Contractile Elements during Postnatal Development of the Epididymis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123960"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1242\/jcs.113.4.587","article-title":"ERGIC-53 and traffic in the secretory pathway","volume":"113","author":"Hauri","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_17","first-page":"43","article-title":"Biological Importance of Glycosylation","volume":"96","author":"Dwek","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.4049\/jimmunol.0802981","article-title":"Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: Possible role in suppressing experimental autoimmune encephalomyelitis","volume":"182","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/eji.200839177","article-title":"Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice","volume":"39","author":"Chou","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-012-0304-1","article-title":"Human deficiencies of fucosylation and sialylation affecting selectin ligands","volume":"34","author":"Wild","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12344","article-title":"Sialic acids and autoimmune disease","volume":"269","author":"Mahajan","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp-2014-309964","article-title":"Sialylated IgG-Fc: A novel biomarker of chronic inflammatory demyelinating polyneuropathy","volume":"87","author":"Wong","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Xu, P.-C., Gou, S.-J., Yang, X.-W., Cui, Z., Jia, X.-Y., Chen, M., and Zhao, M.-H. (2012). Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies. BMC Immunol., 13.","DOI":"10.1186\/1471-2172-13-10"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1021\/pr400589m","article-title":"Association between Galactosylation of Immunoglobulin G and Improvement of Rheumatoid Arthritis during Pregnancy Is Independent of Sialylation","volume":"12","author":"Bondt","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.jprot.2012.02.001","article-title":"Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer","volume":"75","author":"Chen","year":"2012","journal-title":"J. Proteom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.30362","article-title":"Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener\u2019s)","volume":"63","author":"Espy","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_29","first-page":"666","article-title":"Serum Concentrations of Neopterin, Soluble Interleukin 2 Receptor, and Soluble Tumor Necrosis Factor Receptor in Wegener\u2019s Granulomatosis","volume":"24","author":"Nassonov","year":"1997","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10719-009-9239-8","article-title":"Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase","volume":"26","author":"Amith","year":"2009","journal-title":"Glycoconj. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1038\/ncomms7651","article-title":"Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss","volume":"6","author":"Harre","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/annrheumdis-2019-215195","article-title":"Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis","volume":"78","author":"Kurata","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jbspin.2019.01.005","article-title":"Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis\u2014Role for glycosylation","volume":"86","author":"Coutant","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","article-title":"Determination of Severity of Murine IgA Nephropathy by Glomerular Complement Activation by Aberrantly Glycosylated IgA and Immune Complexes","volume":"181","author":"Hashimoto","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.ASN.0000115401.07980.0C","article-title":"Glycosylation and Size of IgA1 Are Essential for Interaction with Mesangial Transferrin Receptor in IgA Nephropathy","volume":"15","author":"Moura","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-3083.1999.00628.x","article-title":"Glycosylation of immunoglobulin A influences its receptor binding","volume":"50","author":"Basset","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-3083.2000.00685.x","article-title":"Increased N-Linked Glycosylation Leading to Oversialylation of Monomeric Immunoglobulin A1 from Patients with Sjogren\u2019s Syndrome","volume":"51","author":"Basset","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome","volume":"67","author":"Gudelj","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3389\/fimmu.2018.01183","article-title":"Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis","volume":"9","author":"Bartsch","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"963230","DOI":"10.1155\/2014\/963230","article-title":"Prevalence of Anti-Neu5Gc Antibodies in Patients with Hypothyroidism","volume":"2014","author":"Eleftheriou","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-3233(08)60451-9","article-title":"Glycoproteins","volume":"27","author":"Spiro","year":"1973","journal-title":"Adv. Protein Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.accb.2018.09.001","article-title":"Exploration of the Sialic Acid World","volume":"Volume 75","author":"Schauer","year":"2018","journal-title":"Advances in Carbohydrate Chemistry and Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Teppa, R., Petit, D., Plechakova, O., Cogez, V., and Harduin-Lepers, A. (2016). Phylogenetic-Derived Insights into the Evolution of Sialylation in Eukaryotes: Comprehensive Analysis of Vertebrate \u03b2-Galactoside \u03b12,3\/6-Sialyltransferases (ST3Gal and ST6Gal). Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081286"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0300-9084(01)01301-3","article-title":"The human sialyltransferase family","volume":"83","author":"Julien","year":"2001","journal-title":"Biochimie"},{"key":"ref_48","first-page":"v","article-title":"Systematic Nomenclature for Sialyltransferases","volume":"6","author":"Tsuji","year":"1996","journal-title":"Glycobiology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/glycob\/cwi063","article-title":"The animal sialyltransferases and sialyltransferase-related genes: A phylogenetic approach","volume":"15","author":"Mollicone","year":"2005","journal-title":"Glycobiology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gkn663","article-title":"The Carbohydrate-Active EnZymes database (CAZy): An expert resource for Glycogenomics","volume":"37","author":"Cantarel","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/glycob\/cwq189","article-title":"Current trends in the structure-activity relationships of sialyltransferases","volume":"21","author":"Audry","year":"2011","journal-title":"Glycobiology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/mcp.M112.026898","article-title":"Comprehensive Quantitative Comparison of the Membrane Proteome, Phosphoproteome, and Sialiome of Human Embryonic and Neural Stem Cells","volume":"13","author":"Schulz","year":"2014","journal-title":"Mol. Cell. Proteom."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cbic.201700083","article-title":"Sialylation Is Dispensable for Early Murine Embryonic Development in Vitro","volume":"18","author":"Abeln","year":"2017","journal-title":"ChemBioChem Eur. J. Chem. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1074\/jbc.M209595200","article-title":"The ST6Gal I Sialyltransferase Selectively Modifies N-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death","volume":"278","author":"Amano","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.1507706113","article-title":"Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells","volume":"113","author":"Perdicchio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.4049\/jimmunol.163.7.3746","article-title":"Alpha(1,3)-Fucosyltransferase VII and Alpha(2,3)-Sialyltransferase IV Are up-Regulated in Activated CD4 T Cells and Maintained after Their Differentiation into Th1 and Migration into In-flammatory Sites","volume":"163","author":"Blander","year":"1999","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3389\/fimmu.2018.02150","article-title":"Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells","volume":"9","author":"Irons","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1073\/pnas.95.13.7469","article-title":"Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes","volume":"95","author":"Razi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"32200","DOI":"10.1074\/jbc.M702341200","article-title":"Human B-lymphocytes Express \u03b12-6-Sialylated 6-Sulfo-N-acetyllactosamine Serving as a Preferred Ligand for CD22\/Siglec-2","volume":"282","author":"Kimura","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.aad0512","article-title":"Polysialylation controls dendritic cell trafficking by regulating chemokine recognition","volume":"351","author":"Kiermaier","year":"2016","journal-title":"Science"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2013.00491","article-title":"Dendritic Cells: A Spot on Sialic Acid","volume":"4","author":"Crespo","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1034\/j.1600-0897.2002.01141.x","article-title":"In Vitro Modulation of Protective Antibody Responses by Estrogen, Progesterone and Interleukin-6: Hormone-Modulated Protective Antibody","volume":"48","author":"Canellada","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The Emerging Importance of IgG Fab Glycosylation in Immunity","volume":"196","author":"Hafkenscheid","year":"2016","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3140621","article-title":"Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients","volume":"314 Pt 2","author":"Youings","year":"1996","journal-title":"Biochem. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1471-4906(01)01873-7","article-title":"IgA and the IgA Fc receptor","volume":"22","author":"Damen","year":"2001","journal-title":"Trends Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00018-018-2976-8","article-title":"The inflammatory function of human IgA","volume":"76","author":"Hansen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1201128","article-title":"Fc\u03b1RI-Mediated Inhibition of IL-12 Production and Priming by IFN-\u03b3 of Human Monocytes and Dendritic Cells","volume":"190","author":"Lecocq","year":"2013","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-019-13992-8","article-title":"IgA subclasses have different effector functions associated with distinct glycosylation profiles","volume":"11","author":"Steffen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri1266","article-title":"Human antibody\u2013Fc receptor interactions illuminated by crystal structures","volume":"4","author":"Woof","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-Dose Intravenous Gammaglobulin for Idiopathic Thrombocytopenic Purpura in Childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet Lond. Engl."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10875-010-9398-1","article-title":"Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"30","author":"Tackenberg","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2016.05.020","article-title":"Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury","volume":"282","author":"Zhang","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaci.2012.02.037","article-title":"Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs","volume":"129","author":"Oefner","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.11.041","article-title":"Engineered Sialylation of Pathogenic Antibodies in Vivo Attenuates Autoimmune Disease","volume":"172","author":"Pagan","year":"2018","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","article-title":"IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes","volume":"116","author":"Cornec","year":"2010","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/sj.leu.2404866","article-title":"Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia","volume":"21","author":"DiJoseph","year":"2007","journal-title":"Leukemia"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/C7NR08430G","article-title":"Endogenous sialic acid-engineered micelles: A multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis","volume":"10","author":"Xu","year":"2018","journal-title":"Nanoscale"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11095-019-2609-4","article-title":"Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment","volume":"36","author":"Hu","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.7150\/thno.19571","article-title":"E-selectin-targeted Sialic Acid-PEG-dexamethasone Micelles for Enhanced Anti-Inflammatory Efficacy for Acute Kidney Injury","volume":"7","author":"Hu","year":"2017","journal-title":"Theranostics"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1586-z","article-title":"Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: A potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women","volume":"20","author":"Engdahl","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12016-019-08741-0","article-title":"Complement System: A Neglected Pathway in Immunotherapy","volume":"58","author":"Bordron","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3402\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:41:20Z","timestamp":1760161280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":86,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22073402"],"URL":"https:\/\/doi.org\/10.3390\/ijms22073402","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}